Is Hangzhou Alltest Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hangzhou Alltest Biotech pays dividends. Last time was Thursday 20th of June 2024 where the investors holding the stock on Thursday 20th of June 2024 were paid CNY1.5 per share. Over the last 4 times between 2021 and 2024, Hangzhou Alltest Biotech has paid CNY22.3 with an average of CNY5.58 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hangzhou Alltest Biotech 10 years ago, but if you had invested on Thursday 25th of March 2021 when the price was CNY117.53, you would have made a loss of CNY-49.34 per share or -41.98%
Yes, the average daily trading liquidity for Hangzhou Alltest Biotech is CNY471 511 thousand. You should therefore be able to get in and out of your positions relatively fast.
Hangzhou Alltest Biotech has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 24.46, the company's ability to pay off the debt is good. Hangzhou Alltest Biotech has a very good net profit margin of 30.56% and should have very high tolerances against inflation.
We have calculated the inflation risk for Hangzhou Alltest Biotech to be low [0 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.